The sector certainly seems in pullpack mode. There is nothing to think that the broader trend higher is broken but obviously that is something we want to keep an eye on. There will be a broader and more significant move lower but global equities saw the largest inflow of funds ever last week. There is […]
February 8th Biotech (and MLP) Update
We have moved past the large cap portion of the earnings with positive price action in the sector but less so in the companies that are reporting. I do not believe that is related to the quality of the earnings as they were generally fine but more of a broader disconnect between large and SMID […]
February 4th Biotech Update
The market seems to have calmed down and now we are entering the grind higher phase (so it seems). I would not argue with you if you were to tell me that the market is overvalued and we are in the late stages of the bull market. I would note, however, that these late stages […]
February 3rd Biotech Update
It seems like the reddit traders and the GME short squeeze neither broke the market or revolutionized it. They were unable to keep the price high and avoid the crash (I suspect the Robinhood restriction only hastened the crash) and the were unable to replicate it in their next target of SLV. So odds are […]
January 29th Biotech Update
Yesterday was interesting and today it seems to have settled down a little. As I noted all week this was going to cause some volatility in the market and it has. I am still not sure if the supposed rise of reddit finance (so to speak) changes the market in any way. It could very […]
January 25th Biotech Update
The week starts as last week ending which is quiet. We are starting to get earnings this week which will pick up the news flow but it is not really into next week that the biotech earnings starting hitting in earnest. This week we generally are getting some large pharma which will help us get […]
January 22nd Biotech Update
Not much happening as seems to be the theme of the week. Perhaps I had some wishful thinking that earnings will kick off at the end of January but it does seem like the first week of February will be the week where it kicks into high gear. As such I would expect another slow […]
January 13th Biotech Update
So I think JPM is a complete failure in terms of news. It is obviously a dud in terms of M&A. I do not remember the last time we had a JPM with zero mergers. There have been some with minor deals but it has been awhile since there have not been any. This actually […]
December 28th Biotech Update
As expected the news is slowing down and there is not a ton of news to talk about today if there is really anything news worthy. Given the lack of news I suspect that the sector and markets will continue the low volume seasonal trade, which means a bullish bias. Perhaps there is an added […]
APLIF – Appili Therapeutics and Avigan, the Antiviral Pill to treat Coronavirus: The Clinical Strategy for EUA
Canada TSX: APLI, US OTCQX: APLIF We previously reported on the need for COVID-19 therapeutics, including in the post-vaccine world, Appili Therapeutics and Avigan the Antiviral Pill to Treat Coronavirus (link here). Since the publication of that report, daily infections have only continued to rise, and nursing facilities and hospitals are facing an intensified crisis. […]
November 23 Biotech Update
The market dynamics remain the same. We are entering what tends to be a seasonally positive period of the year, which might add some tailwind to the broader market. While I still think the market is going to focus on the prospects of the vaccine coming next year as opposed to the out of control […]
APLIF – Appili Therapeutics and Avigan the Antiviral Pill to Treat Coronavirus
Canada TSX: APLI, US OTC: APLIF Recent vaccine news from Pfizer (PFE) and Moderna (MRNA) provide some optimism to a world suffering from disease, death, and lockdown, and desperately looking for a solution to the COVID-19 pandemic for a return to normal life and work. Safe and effective vaccines will help contain the spread of […]
November 20th Biotech Update
I think choppy might have been the best description of the market at this point. This makes sense give the competing influences on both the market and economy. I would not be surprised to see this chop continue or perhaps even see some consolidation. The broader market seems in a little more precarious position than […]
November 19th Biotech Update
Nothing crazy happening in the market at this point. I do not see anything that compelling low or high and I think the market continues to struggle with the hope of the vaccines versus the pain of an out of control spread. There is likely a point where the immediate term gets so bad that […]
November 16th Biotech Update
Another start to the week with some more vaccine announcements (positive). It was good to see more positive vaccine data but it does not change the dynamic that I see with the market. There appears to be a real light at the end of the tunnel but the path to the end will be very […]
November 13th Biotech Update
So its been a decent week and hopefully we can end on a strong note. Not a lot of news to move the market or sector and perhaps that means we get a decent look at the underlying sentiment of the market. We are past the major catalysts of November and there is really not […]
November 11th Biotech Update
Below are my comments on the guidelines that you can forward along. So it looks like the market has digested the outcome of the election for the most part. I still think there is going to be a tug of war in terms of COVID with the vaccine news pushing the post-COVID names but […]
November 9th Biotech Update
We do not have merger Monday, so I suspect the market will be disappointed. I joke of course as this is going to be a massive relief rally on the news of the PFE vaccine. While there will certainly be a rally that raises almost everyone, there will likely be rotations out of COVID treatment […]
October 28th Biotech Update
Not a great start to the week (or continuation of the week) as the market and sector continue to struggle. Given all of the potential news makers in the next couple weeks it is difficult to completely attribute the move solely to one factor. My mantra has been that the trend is your friend and […]
October 1st Biotech Update
The sector has been a grind this week in that it appears unable to move higher but also is not breaking down at all. Every rally appears to be sold or unable to get any real traction (the open today is a perfect example in that it looks like we could have a good day […]
